Atlassian Insider Sold Shares Worth $2,000,489, According to a Recent SEC Filing-February 2024-www.financetom.com

Atlassian Insider Sold Shares Worth $2,000,489, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Atlassian Insider Sold Shares Worth $2,000,489, According to a Recent SEC Filing

Nov 15, 2024 1:54 PM

04:28 PM EST, 11/15/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on November 14, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $2,000,489. Following the Form 4 filing with the SEC, Farquhar has control over a total of 246,388 shares of the company, with 246,388 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000156218024007725/xslF345X05/primarydocument.xml

Previous page： Airo Group Closes $89.4 Million Common Stock Offering Next page： NovoCure's Optune Lua Receives Approval in Japan to Treat Certain Non-Small Cell Lung Cancer Patients

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Airo Group Closes $89.4 Million Common Stock Offering

Sep 15, 2025

07:49 AM EDT, 09/15/2025 (MT Newswires) -- Airo Group Holdings ( AIRO ) said Monday it closed an upsized public offering of 4.83 million common shares, for about $89.4 million in gross proceeds. The company said the offering includes the full exercise of the underwriters' option to buy 630,000 additional shares. Airo ( AIRO ) plans to use the net...

NovoCure's Optune Lua Receives Approval in Japan to Treat Certain Non-Small Cell Lung Cancer Patients

Sep 15, 2025

07:46 AM EDT, 09/15/2025 (MT Newswires) -- NovoCure ( NVCR ) said Monday that Japan's Ministry of Health, Labour and Welfare has approved Optune Lua for concurrent use with PD-1/PD-L1 inhibitors to treat certain adult patients with non-small cell lung cancer. Optune Lua is a wearable, portable medical device that produces alternating electric fields that kill cancer cells, the company...

Intel Lowers 2025 Expense Outlook After Altera Sale

Sep 15, 2025

07:49 AM EDT, 09/15/2025 (MT Newswires) -- Intel ( INTC ) said Monday in a Form 8-K filing that it now expects full-year 2025 non-GAAP operating expense of $16.8 billion, down from prior outlook of $17 billion, following the deconsolidation of its programmable chip unit, Altera. Analyst estimates were not available for comparison. Intel ( INTC ) said the sale...

Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report

Sep 15, 2025

Corteva Inc. ( CTVA ) is reportedly considering a major restructuring that would split its seed and pesticide operations into two separate entities. The pure-play agriculture company, valued at roughly $50 billion, could announce its plans soon if negotiations stay on track. Corteva ( CTVA ) offers a portfolio of seed and crop protection solutions. The move would mark another significant...